Targeting CD20 in melanoma patients at high risk of disease recurrence.
Pinc A, Somasundaram R, Wagner C, Hörmann M, Karanikas G, Jalili A, Bauer W, Brunner P, Grabmeier-Pfistershammer K, Gschaider M, Lai CY, Hsu MY, Herlyn M, Stingl G, Wagner SN.
Pinc A, et al.
Mol Ther. 2012 May;20(5):1056-62. doi: 10.1038/mt.2012.27. Epub 2012 Feb 21.
Mol Ther. 2012.
PMID: 22354376
Free PMC article.
Clinical Trial.